Does PONATINIB Cause Ejection fraction decreased? 32 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 32 reports of Ejection fraction decreased have been filed in association with PONATINIB (Iclusig). This represents 0.3% of all adverse event reports for PONATINIB.
32
Reports of Ejection fraction decreased with PONATINIB
0.3%
of all PONATINIB reports
9
Deaths
20
Hospitalizations
How Dangerous Is Ejection fraction decreased From PONATINIB?
Of the 32 reports, 9 (28.1%) resulted in death, 20 (62.5%) required hospitalization, and 4 (12.5%) were considered life-threatening.
Is Ejection fraction decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PONATINIB. However, 32 reports have been filed with the FAERS database.
What Other Side Effects Does PONATINIB Cause?
Death (1,735)
Off label use (1,071)
Product dose omission issue (817)
Fatigue (687)
Rash (639)
Headache (553)
Pyrexia (542)
Nausea (466)
Hospitalisation (459)
Constipation (435)
What Other Drugs Cause Ejection fraction decreased?
SACUBITRIL\VALSARTAN (2,551)
TRASTUZUMAB (1,579)
DOXORUBICIN (834)
CYCLOPHOSPHAMIDE (754)
PERTUZUMAB (644)
DOCETAXEL (520)
PACLITAXEL (466)
BISOPROLOL (314)
RITUXIMAB (296)
CARVEDILOL (284)
Which PONATINIB Alternatives Have Lower Ejection fraction decreased Risk?
PONATINIB vs PONATINIB\PONATINIB
PONATINIB vs PONESIMOD
PONATINIB vs PORACTANT ALFA
PONATINIB vs PORFIMER
PONATINIB vs POSACONAZOLE